Real-World German Clinical Data Clarify Practical Management for Subcutaneous Foslevodopa Therapy
A clinical review synthesizes two years of real-world German experience with continuous subcutaneous foslevodopa/foscarbidopa infusion for advanced Parkinson's disease.

